HER3-BINDENDE POLYPEPTIDE

European patent · EP2904013 · In force

Register entry

Publication number
EP2904013
Application number
EP13774385
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 3, 2013
Published
Aug 12, 2015
Granted
Nov 7, 2018
Protection ends at the latest
Oct 2, 2033
Next annual fee due
Oct 31, 2026
IPC classes
C07K 16/32 (2006.01)
C07K 14/705 (2006.01)
Priority
EP 12187457 05.10.2012
US 201261710051 P 05.10.2012
EP 13151882 18.01.2013
US 201361753963 P 18.01.2013
PCT application
PCT/EP2013/070605 03.10.2013
PCT publication
WO2014/053586 10.04.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Jan 15, 2025

    Agent removed

    Representative
    OFFICE ERNEST T. FREYLINGER S.A., c/o SCHLUEP & DEGEN, P.O. BOX 8062, 3001 Bern (removed)

    Published in Swissreg on 15.01.2025

  3. Jan 15, 2025

    Agent entered

    Representative
    OFFICE ERNEST FREYLINGER S.A., c/o Schluep IP Law AG, Falkenplatz 7, 3012 Bern

    Published in Swissreg on 15.01.2025

  4. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  5. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  6. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  7. Jan 19, 2019

    Agent entered

    Representative
    OFFICE ERNEST T. FREYLINGER S.A., c/o SCHLUEP & DEGEN, P.O. BOX 8062, 3001 Bern

    Published in Swissreg on 19.01.2019

  8. Nov 7, 2018

    Granted

    Published in Swissreg on 07.11.2018

Parties

Inventor

STÅHL, Stefan

111 40 Stockholm, SE

MALM, Magdalena

120 70 Stockholm, SE

LÖFBLOM, John

141 37 Huddinge, SE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.